Efficacy of Perioperative Continuous Intravenous Lidocaine Infusion for 72 Hours on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy: Study Protocol for a Prospective Randomized Controlled Trial

被引:7
|
作者
Xu, Yan [1 ,2 ]
Ye, Mao [1 ,2 ]
Hong, Ying [1 ,2 ]
Kang, Yi [1 ,3 ]
Li, Yue [1 ,2 ]
Xiao, Xiao [1 ,2 ]
Zhou, Li [1 ,2 ]
Jiang, Chunling [1 ,2 ]
机构
[1] Sichuan Univ, Dept Anesthesiol, West China Hosp, Chengdu 610041, Peoples R China
[2] Chinese Acad Med Sci, Res Units West China 2018RU012, Chengdu 610041, Peoples R China
[3] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Lab Anesthesia & Crit Care Med, Chengdu 610041, Peoples R China
来源
JOURNAL OF PAIN RESEARCH | 2021年 / 14卷
基金
中国国家自然科学基金;
关键词
intravenous lidocaine; hepatectomy; postoperative pain; recovery; LAPAROSCOPIC CHOLECYSTECTOMY; PULMONARY COMPLICATIONS; SURGERY; METAANALYSIS; MANAGEMENT; ANESTHESIA; ANALGESIA; RELIEF; SAFETY;
D O I
10.2147/JPR.S341550
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Many patients develop severe and persistent pain after hepatectomy delaying postoperative rehabilitation. Studies have suggested that intravenous lidocaine infusion relieved postoperative pain and improved overall postoperative outcomes. However, its efficacy on hepatectomy is still masked, due to the postoperative metabolic change of lidocaine by the liver. We hypothesized that intravenous lidocaine infusion in the perioperative period would lead to postoperative pain reduction and improve the overall patient experience. Study Design and Methods: In this prospective double-blind, randomized controlled design trial, 260 adults scheduled for hepatectomy will be allocated to the lidocaine and the placebo groups. The lidocaine group will be administered lidocaine intravenously during intraoperative period and 72 postoperative hours; the placebo group will be administered normal saline at the same volume, infusion rate, and timing. The primary outcome is the incidence of moderate-severe pain (numeric rating scale >= 4) during movement at 24 hours after surgery. The secondary outcomes include the incidence of moderate-severe pain at 24 hours after surgery at rest, the incidence of moderate-severe pain at 48 and 72 hours after surgery at rest and during movement, the cumulative morphine consumption at 24, 48 and 72 hours postoperatively, bowel function recovery, the incidence of postoperative nausea and vomiting, the incidence of postoperative pulmonary complications, the length of hospital stay, levels of inflammatory factors and patient satisfaction scores. Discussion: This is the first prospective trial to shed light on the efficacy of intraoperative period and 72 postoperative hours intravenous lidocaine on postoperative pain and recovery after hepatectomy. The findings will provide a new strategy of perioperative pain management for hepatectomy.
引用
收藏
页码:3665 / 3674
页数:10
相关论文
共 50 条
  • [1] Effect of Perioperative Intravenous Lidocaine on Postoperative Recovery in Patients Undergoing Ileostomy Closure: Study Protocol for a Randomized Controlled Trial
    Liu, Jia
    Liu, Kun
    Wang, Huixian
    Hu, Hongli
    Sun, Guolin
    Ye, Xiaofei
    Lou, Zheng
    Bian, Jinjun
    Bo, Lulong
    JOURNAL OF PAIN RESEARCH, 2022, 15 : 1863 - 1872
  • [2] Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery
    Kranke, Peter
    Jokinen, Johanna
    Pace, Nathan Leon
    Schnabel, Alexander
    Hollmann, Markus W.
    Hahnenkamp, Klaus
    Eberhart, Leopold H. J.
    Poepping, Daniel M.
    Weibel, Stephanie
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (07):
  • [3] Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults
    Weibel, Stephanie
    Jelting, Yvonne
    Pace, Nathan L.
    Helf, Antonia
    Eberhart, Leopold H. J.
    Hahnenkamp, Klaus
    Hollmann, Markus W.
    Poepping, Daniel M.
    Schnabel, Alexander
    Kranke, Peter
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (06):
  • [4] Effect of Intravenous Lidocaine on Postoperative Pain in Patients Undergoing Intraspinal Tumor Resection: Study Protocol for a Prospective Randomized Controlled Trial
    Yue, Hongli
    Zhou, Man
    Lu, Yu
    Chen, Liang
    Cui, Weihua
    JOURNAL OF PAIN RESEARCH, 2020, 13 : 1401 - 1410
  • [5] Postoperative analgesic efficacy of perioperative intravenous lidocaine infusion in patients undergoing septorhinoplasty: a prospective, randomized, double-blind study
    Ates, Irem
    Aydin, Muhammed Enes
    Ahiskalioglu, Ali
    Ahiskalioglu, Elif Oral
    Kaya, Zulkuf
    Gozeler, Mustafa Sitki
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (04) : 1095 - 1100
  • [6] Postoperative analgesic efficacy of perioperative intravenous lidocaine infusion in patients undergoing septorhinoplasty: a prospective, randomized, double-blind study
    İrem Ates
    Muhammed Enes Aydin
    Ali Ahiskalioglu
    Elif Oral Ahiskalioglu
    Zulkuf Kaya
    Mustafa Sitki Gozeler
    European Archives of Oto-Rhino-Laryngology, 2020, 277 : 1095 - 1100
  • [7] Perioperative Intravenous Lidocaine Infusion on Postoperative Recovery in Patients Undergoing Arthroscopic Rotator Cuff Repair Under General Anesthesia A Randomized Controlled Trial
    Kim, Seon Ju
    Choi, Yong Seon
    Chun, Yong Min
    Kim, Hye Jin
    Han, Chunggu
    Shin, Seokyung
    CLINICAL JOURNAL OF PAIN, 2022, 38 (01): : 1 - 7
  • [8] Impact of perioperative intravenous lidocaine infusion on postoperative pain and rapid recovery of patients undergoing gastrointestinal tumor surgery: a randomized, double-blind trial
    Dai, Yue'e
    Jiang, Rong
    Su, Wenjie
    Wang, Man
    Liu, Yue
    Zuo, Yunxia
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1274 - 1282
  • [9] Effect of perioperative intravenous lidocaine infusion on postoperative recovery following laparoscopic Cholecystectomy-A randomized controlled trial
    Song, Xiaoli
    Sun, Yanxia
    Zhang, Xiaomei
    Li, Tianzuo
    Yang, Binbin
    INTERNATIONAL JOURNAL OF SURGERY, 2017, 45 : 8 - 13
  • [10] Effect of intravenous lidocaine infusion on perioperative cellular immunity and the quality of postoperative recovery in breast cancer patients: a randomized controlled trial
    Wei, Qingfeng
    Xia, Ming
    Zhang, Qin
    Wang, Zhiping
    GLAND SURGERY, 2022, 11 (03) : 599 - 610